• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肌肉糖原贮积病 0 表现为反复晕厥伴无力和肌痛。

Muscle glycogen storage disease 0 presenting recurrent syncope with weakness and myalgia.

机构信息

Department of Child Neurology, National Center Hospital, National Center of Neurology and Psychiatry, Kodaira, Tokyo, Japan.

出版信息

Neuromuscul Disord. 2012 Feb;22(2):162-5. doi: 10.1016/j.nmd.2011.08.008. Epub 2011 Sep 29.

DOI:10.1016/j.nmd.2011.08.008
PMID:21958591
Abstract

Muscle glycogen storage disease 0 (GSD0) is caused by glycogen depletion in skeletal and cardiac muscles due to deficiency of glycogen synthase 1 (GYS1), which is encoded by the GYS1 gene. Only two families with this disease have been identified. We report a new muscle GSD0 patient, a Japanese girl, who had been suffering from recurrent attacks of exertional syncope accompanied by muscle weakness and pain since age 5 years until she died of cardiac arrest at age 12. Muscle biopsy at age 11 years showed glycogen depletion in all muscle fibers. Her loss of consciousness was gradual and lasted for hours, suggesting that the syncope may not be simply caused by cardiac event but probably also contributed by metabolic distress.

摘要

肌肉糖原贮积症 0 型(GSD0)是由于糖原合酶 1(GYS1)缺乏导致骨骼肌和心肌中的糖原耗竭引起的,该基因由 GYS1 基因编码。目前仅发现了两个具有这种疾病的家族。我们报告了一位新的肌肉 GSD0 患者,一名日本女孩,她从 5 岁开始反复发作劳累性晕厥,伴有肌肉无力和疼痛,直到 12 岁因心脏骤停而死亡。11 岁时的肌肉活检显示所有肌纤维均有糖原耗竭。她的意识丧失是逐渐发生的,持续数小时,这表明晕厥可能不仅仅是由心脏事件引起的,还可能与代谢窘迫有关。

相似文献

1
Muscle glycogen storage disease 0 presenting recurrent syncope with weakness and myalgia.肌肉糖原贮积病 0 表现为反复晕厥伴无力和肌痛。
Neuromuscul Disord. 2012 Feb;22(2):162-5. doi: 10.1016/j.nmd.2011.08.008. Epub 2011 Sep 29.
2
Glycogen synthase deficiency (glycogen storage disease type 0) presenting with hyperglycemia and glucosuria: report of three new mutations.糖原合酶缺乏症(0型糖原贮积病)伴高血糖和糖尿:三个新突变的报告
J Pediatr. 2002 Jun;140(6):781-3. doi: 10.1067/mpd.2002.124317.
3
Cardiomyopathy and exercise intolerance in muscle glycogen storage disease 0.肌肉糖原贮积病0型中的心肌病与运动不耐受
N Engl J Med. 2007 Oct 11;357(15):1507-14. doi: 10.1056/NEJMoa066691.
4
Comparative skeletal muscle histopathologic and ultrastructural features in two forms of polysaccharide storage myopathy in horses.两种马多糖贮积性肌病的骨骼肌肉组织病理和超微结构特征比较。
Vet Pathol. 2009 Nov;46(6):1281-91. doi: 10.1354/vp.08-VP-0177-M-FL. Epub 2009 Jul 15.
5
Polysaccharide storage myopathy phenotype in quarter horse-related breeds is modified by the presence of an RYR1 mutation.四分之一马相关品种中的多糖贮积性肌病表型因RYR1突变的存在而改变。
Neuromuscul Disord. 2009 Jan;19(1):37-43. doi: 10.1016/j.nmd.2008.10.001. Epub 2008 Dec 3.
6
Hepatic glycogen synthase deficiency: an infrequently recognized cause of ketotic hypoglycemia.肝糖原合酶缺乏症:一种较少被认识到的酮症性低血糖病因。
Mol Genet Metab. 2006 Apr;87(4):284-8. doi: 10.1016/j.ymgme.2005.10.006. Epub 2005 Dec 6.
7
The variable clinical phenotype of three patients with hepatic glycogen synthase deficiency.三名肝糖原合酶缺乏症患者的可变临床表型。
J Pediatr Endocrinol Metab. 2017 Apr 1;30(4):459-462. doi: 10.1515/jpem-2016-0317.
8
A GYS1 gene mutation is highly associated with polysaccharide storage myopathy in Cob Normand draught horses.糖原合成酶1(GYS1)基因突变与诺曼底役马的多糖贮积性肌病高度相关。
Anim Genet. 2009 Feb;40(1):94-6. doi: 10.1111/j.1365-2052.2008.01778.x. Epub 2008 Sep 24.
9
The variable clinical phenotype of liver glycogen synthase deficiency.
J Pediatr Endocrinol Metab. 2007 Dec;20(12):1339-42. doi: 10.1515/jpem.2007.20.12.1339.
10
A glycogen synthase 1 mutation associated with equine polysaccharide storage myopathy and exertional rhabdomyolysis occurs in a variety of UK breeds.一种与马属动物多糖贮积性肌病和运动性横纹肌溶解相关的糖原合酶1突变存在于多种英国马品种中。
Equine Vet J. 2009 Jul;41(6):597-601. doi: 10.2746/042516409x407611.

引用本文的文献

1
Cardiovascular involvement in glycogen storage diseases.糖原贮积病的心血管受累情况。
Nat Rev Cardiol. 2025 Jun 5. doi: 10.1038/s41569-025-01171-w.
2
Expanding therapeutic options for Pompe disease: a new small molecule inhibitor of glycogen synthase 1 (GYS1) shows preclinical promise in Pompe disease.拓展庞贝病的治疗选择:一种新型糖原合酶1(GYS1)小分子抑制剂在庞贝病的临床前研究中显示出前景。
Ann Transl Med. 2024 Dec 24;12(6):123. doi: 10.21037/atm-24-135. Epub 2024 Nov 15.
3
Neurological glycogen storage diseases and emerging therapeutics.
神经糖原贮积病和新兴治疗方法。
Neurotherapeutics. 2024 Sep;21(5):e00446. doi: 10.1016/j.neurot.2024.e00446. Epub 2024 Sep 14.
4
regulates maternal glycogen reserve essential for embryonic development in zebrafish.调节斑马鱼胚胎发育所必需的母体糖原储备。
Heliyon. 2024 May 14;10(10):e31149. doi: 10.1016/j.heliyon.2024.e31149. eCollection 2024 May 30.
5
Small-molecule inhibition of glycogen synthase 1 for the treatment of Pompe disease and other glycogen storage disorders.小分子抑制糖原合酶 1 治疗庞贝病和其他糖原贮积症。
Sci Transl Med. 2024 Jan 17;16(730):eadf1691. doi: 10.1126/scitranslmed.adf1691.
6
MicroRNA-92b in the skeletal muscle regulates exercise capacity via modulation of glucose metabolism.骨骼肌中的 microRNA-92b 通过调节葡萄糖代谢来调节运动能力。
J Cachexia Sarcopenia Muscle. 2023 Dec;14(6):2925-2938. doi: 10.1002/jcsm.13377. Epub 2023 Nov 20.
7
Gys1 Antisense Therapy Prevents Disease-Driving Aggregates and Epileptiform Discharges in a Lafora Disease Mouse Model.Gys1 反义疗法可预防拉佛拉病小鼠模型中的致病聚集物和癫痫样放电。
Neurotherapeutics. 2023 Oct;20(6):1808-1819. doi: 10.1007/s13311-023-01434-9. Epub 2023 Sep 12.
8
Metabolic Cardiomyopathies and Cardiac Defects in Inherited Disorders of Carbohydrate Metabolism: A Systematic Review.遗传性碳水化合物代谢紊乱相关的代谢性心肌病和心脏缺陷:系统综述。
Int J Mol Sci. 2023 May 11;24(10):8632. doi: 10.3390/ijms24108632.
9
A century of exercise physiology: key concepts in regulation of glycogen metabolism in skeletal muscle.一个世纪的运动生理学:骨骼肌中糖原代谢调节的关键概念。
Eur J Appl Physiol. 2022 Aug;122(8):1751-1772. doi: 10.1007/s00421-022-04935-1. Epub 2022 Mar 30.
10
Gys1 antisense therapy rescues neuropathological bases of murine Lafora disease.Gys1 反义疗法可挽救小鼠拉福拉病的神经病理学基础。
Brain. 2021 Nov 29;144(10):2985-2993. doi: 10.1093/brain/awab194.